DCGI approves indigenous mRNA Covid jab for emergency use in 18 years & above; Covovax for 7-11 years
NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19...
Covovax
SII’s Covovax receives emergency approval for children aged 12-17 years
NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the 12-17...
